Sotera Health (NASDAQ:SHC) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC reduced its position in shares of Sotera Health (NASDAQ:SHC) by 4.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,147 shares of the company’s stock after selling 3,177 shares during the period. Mutual of America Capital Management LLC’s holdings in Sotera Health were worth $1,030,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in SHC. DekaBank Deutsche Girozentrale acquired a new position in shares of Sotera Health during the third quarter worth $58,000. Pinkerton Retirement Specialists LLC acquired a new position in shares of Sotera Health during the third quarter worth $220,000. Duality Advisers LP acquired a new position in shares of Sotera Health during the third quarter worth $244,000. Balboa Wealth Partners bought a new stake in shares of Sotera Health in the third quarter worth $250,000. Finally, Pacer Advisors Inc. increased its stake in shares of Sotera Health by 79.4% in the fourth quarter. Pacer Advisors Inc. now owns 14,864 shares of the company’s stock worth $250,000 after buying an additional 6,580 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently issued reports on SHC shares. Royal Bank of Canada restated an “outperform” rating and issued a $20.00 price target on shares of Sotera Health in a research note on Monday, March 4th. Barclays dropped their price target on shares of Sotera Health from $19.00 to $14.00 and set an “overweight” rating for the company in a research note on Wednesday, April 10th. Jefferies Financial Group upgraded shares of Sotera Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $15.00 to $15.50 in a research note on Monday, March 25th. Citigroup upgraded shares of Sotera Health from a “neutral” rating to a “buy” rating and dropped their price target for the stock from $18.00 to $16.00 in a research note on Wednesday, April 3rd. Finally, KeyCorp initiated coverage on shares of Sotera Health in a research note on Tuesday, February 6th. They issued a “sector weight” rating for the company. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $17.70.

Insider Transactions at Sotera Health

In other news, Director Pincus & Co. Warburg sold 16,594,363 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.31, for a total transaction of $237,465,334.53. Following the completion of the transaction, the director now owns 88,822,952 shares in the company, valued at $1,271,056,443.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Michael P. Rutz sold 83,109 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.31, for a total transaction of $1,189,289.79. Following the completion of the transaction, the insider now owns 544,409 shares in the company, valued at $7,790,492.79. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Pincus & Co. Warburg sold 16,594,363 shares of the company’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.31, for a total transaction of $237,465,334.53. Following the completion of the sale, the director now directly owns 88,822,952 shares of the company’s stock, valued at approximately $1,271,056,443.12. The disclosure for this sale can be found here. Insiders own 65.13% of the company’s stock.

Sotera Health Stock Up 1.3 %

SHC stock opened at $11.09 on Tuesday. The company has a debt-to-equity ratio of 5.16, a current ratio of 2.42 and a quick ratio of 2.21. Sotera Health has a 1-year low of $10.71 and a 1-year high of $19.40. The firm has a fifty day moving average price of $13.40 and a two-hundred day moving average price of $14.18. The firm has a market cap of $3.14 billion, a price-to-earnings ratio of 61.61 and a beta of 2.11.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, February 27th. The company reported $0.26 earnings per share for the quarter, meeting the consensus estimate of $0.26. The firm had revenue of $310.24 million during the quarter, compared to analyst estimates of $302.17 million. Sotera Health had a net margin of 4.90% and a return on equity of 51.32%. The firm’s revenue for the quarter was up 23.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.23 earnings per share. Research analysts predict that Sotera Health will post 0.64 EPS for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.